Endocrine Therapy of Breast Cancer V edited by A. Goldhirsch.

The European School of Oncology came into existence to respond to a need for informa­ tion, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons why such an initiative was considered necessary. Firstly, the teaching of oncology requires a rigorousl...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Goldhirsch, A. (Editor)
Format: eBook
Language:English
Published: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 1992.
Edition:1st ed. 1992.
Series:ESO Monographs, European School of Oncology
Springer eBook Collection.
Subjects:
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.
Table of Contents:
  • Normal Cell Lineages and the Phenotype of the Breast Cancer Cell
  • The Oestrogen-Regulated pS2-BCEI Protein in Breast Cancer
  • Do All Roads Lead to the Oestrogen Receptor?
  • Tamoxifen for the Treatment of Breast Cancer in the Premenopausal Patient
  • The Multi-Drug Resistance Phenotype and its Reversal by Drugs (with Special Emphasis on Anti-Oestrogens)
  • New Endocrine Agents for Breast Cancer
  • Prognostic Factors in Primary Breast Cancer: Second Thoughts
  • The Contribution of Perturbed Epithelial-Mesenchymal Interactions to Cancer Pathogenesis
  • Reporting Results from Adjuvant Therapy Trials with Special Emphasis on Quality-of-Life Findings
  • Adjuvant Chemoendocrine Therapies in Pre- and Postmenopausal Breast Cancer.